Utrecht, Netherlands

Laura Buttafoco

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Laura Buttafoco: Innovator in Pharmaceutical Compositions

Introduction

Laura Buttafoco is a notable inventor based in Utrecht, Netherlands. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory bowel disease (IBD). Her innovative work has led to the development of a unique pharmaceutical composition that addresses this medical condition.

Latest Patents

Laura Buttafoco holds one patent for her invention titled "Pharmaceutical compositions for treating IBD." This patent describes a stable and/or synergistic pharmaceutical composition that includes predinisolone metasulfobenzoate (PMSB) or its acceptable salts, preferably prednisolone metasulfobenzoate sodium, and 5-ASA, derivatives or pharmaceutically acceptable salts thereof, which is suitable for rectal administration. This invention represents a significant advancement in the treatment options available for patients suffering from IBD.

Career Highlights

Throughout her career, Laura has worked with reputable companies in the pharmaceutical industry. Notably, she has been associated with Nordic Pharma and Disphar International B.V. Her experience in these organizations has contributed to her expertise and success as an inventor.

Collaborations

Laura has collaborated with several professionals in her field, including Hans Schram and Michael Ikechukwu Ugwoke. These collaborations have likely enriched her work and expanded her impact in the pharmaceutical sector.

Conclusion

Laura Buttafoco is a pioneering inventor whose work in pharmaceutical compositions has the potential to improve the lives of many individuals suffering from IBD. Her contributions to the field exemplify the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…